Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Medtronic
Mallinckrodt
Merck
Harvard Business School

Last Updated: January 27, 2023

CLINICAL TRIALS PROFILE FOR PREGNYL


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Pregnyl

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00415766 ↗ Comparison Between Recombinant Versus Urinary hCG for Ovulation Induction in High Responders Unknown status Eugonia Phase 4 2013-06-01 The purpose of this study is to compare the clinical outcomes of recombinant human chorionic gonadotrophin (rHCG) and urinary HCG (uHCG) in patients undergoing IVF cycles.
NCT00415792 ↗ Comparison Between hCG and GnRH Agonist for Ovulation Induction in Patients With High Response to IVF Drugs Unknown status Eugonia Phase 4 2003-11-01 hCG and GnRH agonist can be used to induce final oocyte maturation and ovulation in IVF cycles. These two approaches will be compared in this study in terms of pregnancy rates and embryological data using patients with hyper-response to IVF drugs.
NCT00627406 ↗ Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles Completed Regionshospitalet Viborg, Skive Phase 4 2009-01-01 The purpose of this study is to possibly further improve the clinical outcome and explore the incidence of OHSS in patients, who have final oocyte maturation with GnRHa (Buserelin) in GnRH antagonist IVF/ICSI cycles
NCT00809107 ↗ Frozen Embryo Transfer (FET) in Natural Cycles or in Natural Cycles Controlled by Human Chorionic Gonadotropin (hCG) Administration Completed Universitair Ziekenhuis Brussel N/A 2006-10-01 The rational of the study is to assess the implantation, pregnancy and live birth rates after the transfer of frozen- thawed embryos in natural cycles with spontaneous Luteinizing Hormone (LH)/Progesterone rise or in natural cycles controlled by human chorionic gonadotropin (hCG) for final oocyte maturation and ovulation.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Pregnyl

Condition Name

Condition Name for Pregnyl
Intervention Trials
Infertility 12
Polycystic Ovary Syndrome 5
Invitro Fertilization 2
Female Infertility 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Pregnyl
Intervention Trials
Infertility 16
Polycystic Ovary Syndrome 5
Infertility, Female 3
Syndrome 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Pregnyl

Trials by Country

Trials by Country for Pregnyl
Location Trials
Egypt 10
Belgium 5
United States 4
Greece 4
Iran, Islamic Republic of 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Pregnyl
Location Trials
Minnesota 2
Connecticut 1
Washington 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Pregnyl

Clinical Trial Phase

Clinical Trial Phase for Pregnyl
Clinical Trial Phase Trials
Phase 4 15
Phase 3 1
Phase 2/Phase 3 5
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Pregnyl
Clinical Trial Phase Trials
Completed 18
Unknown status 11
Terminated 3
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Pregnyl

Sponsor Name

Sponsor Name for Pregnyl
Sponsor Trials
Universitair Ziekenhuis Brussel 3
Cairo University 3
Lito Maternity Hospital 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Pregnyl
Sponsor Trials
Other 47
Industry 3
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
McKesson
Dow
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.